Figure 2 2 Data of efficacy 2.1 Clinical trials: the SURPASS program The central clinical trial program designed to demonstrate the therapeutic effectiveness (in terms of GC and BW reduction), tolerability and safety of TZP in diabetic patients was the SURPASS program
Therefore, cellular models are a critical resource to understand dysgenesis and to advance our understanding of human infertility
Different injections given in close sequence can complicate local healing and make it harder to tell where a reaction comes from
218(2): 41727 Kuroda N, Ohyama Y, Nakashima K, et al
Genetic data should be interpreted with your provider alongside clinical history, biomarkers, and lifestyle factors to support a personalized treatment discussion
The in vivo pharmacokinetic and pharmacological properties should be investigated (Zhu et al., 2022b)